The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 1.00 (2.44%)
Spread: 2.00 (4.878%)
Open: 41.00
High: 42.00
Low: 41.00
Prev. Close: 42.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Energy Sector Collaboration

26 Jul 2013 07:00

RNS Number : 1916K
Frontier IP Group plc
26 July 2013
 



 

AIM: FIPP

 

Frontier IP Group Plc

("Frontier IP")

 

Exciting New Energy Sector Collaboration

 

Frontier IP, which specialises in the commercialisation of university intellectual property, is pleased to announce that it has signed an innovative renewable energy sector collaboration with Spanish power group IBERDROLA ("Iberdrola") and renewable energy financial services group Narec Capital Limited ("Narec Capital"). The three parties have signed a memorandum of understanding ("the Memorandum") setting out how they will co-operate to provide investment and industrial leadership for promising clean technology companies.

 

Narec Capital intends to launch its Accelerated Renewable Deployment Portfolio ("ARDP"), with a target fund size of up to £50m that aims to accelerate deployment timeframes and reduce the cost of energy for renewable projects. The Memorandum sets out how Iberdrola will work alongside the ARDP as both a co-investment and industrial partner. Fundraising for the ARDP is underway and both parties are already engaged in assessing and refining a joint deal pipeline.

 

Iberdrola, Spain's leading energy group and one of the world's top power companies with a world leading position in renewable energy, invests in innovative energy technologies and businesses through its corporate venture capital program, PERSEO.

 

Narec Capital provides specialist financial advice to companies and projects within the renewable energy sector. Frontier IP, which is quoted on AIM, specialises in the commercialisation of university intellectual property and has an agreement in place with Narec Capital to provide fund management and administration services to the ARDP.

 

This collaboration brings together financial and industry expertise which will be combined to support investee companies in the energy sector in the development and deployment of their technologies.

 

Jerry Biggs, Chief Executive, Narec Capital said,

 

"There is not only an acute equity gap being experienced by technology companies within this sector but also an obvious adoption gap by the industrial partners who are able to take the technologies through to full operational deployment. The collaboration between our new ARDP fund and Iberdrola Perseo will help to ensure that technologies are selected that have direct application for industry. By applying Narec Capital's rigorous due diligence and commercialisation process alongside Iberdrola's industrial pull through capability, we can help to mitigate risk of failure, address the funding and adoption gap and increase investment returns."

 

Agustín Delgado, Director of Innovation, Environment and Quality, Iberdrola said,

 

"This new partnership will bring us the opportunity to collaborate with two organisations that are a reference in technology development for the renewable sector in the UK. For Iberdrola this is an excellent tool to continue supporting the entrepreneurial ecosystem that is key for addressing the future challenges of the energy sector."

 

Neil Crabb, Chief Executive, Frontier IP said,

 

"This is an exciting partnership and brings together a range of expertise to focus on finding and investing in companies with new technologies in the energy sector. In particular we are interested in renewable electrical energy generation technologies as well as technologies that reduce the environmental impact of existing generation systems. Through our knowledge of the renewable energy sector and experience in raising and managing funds, we hope to play an important part in the success of this new collaboration."

 

 Enquiries

Frontier IP Group Plc

T: 0131 220 9491

Neil Crabb, Chief Executive

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

T: 020 7894 7000

Mark Percy / Julian Erleigh, Corporate Finance

David Banks / Paul Jewell, Corporate Broking

Peterhouse Corporate Finance Limited (Joint Broker)

T: 020 7469 0935

Jon Levinson / Lucy Williams

Biddicks

T: 020 3178 6378

Katie Tzouliadis

 

 

Notes to Editor:

 

Narec Capital is the UK's renewable energy accelerator. The company is a uniquely positioned financial services company with a primary focus on reducing financial risk and providing capital in order to accelerate the deployment and reduce the cost per megawatt hour of renewable energy technologies and projects. www.nareccapital.com 

 

PERSEO is IBERDROLA's corporate venture capital program to invest in the technologies that will help shaping the future of energy. Since its creation in 2008, more than €25M have already been invested through this program in start-up companies around the globe that develop technologies and new businesses in the energy sector.

 

Frontier IP specialises in the commercialisation of Intellectual Property. It establishes partnerships with individual universities and research institutions to assist with their spin-out and licensing activities and helps to maximise the commercial value of technologies emerging from their research programmes. www.frontierip.co.uk 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFEEDRIEFIV
Date   Source Headline
7th May 202410:15 amRNSTVG to collaborate with The Pirbright Institute
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.